Clinical Trials Logo

Infections clinical trials

View clinical trials related to Infections.

Filter by:

NCT ID: NCT06120153 Recruiting - Clinical trials for Respiratory Tract Infections

Point of Care Polymerase Chain Reaction (PCR) Diagnostics of Respiratory Tract Infections in General Practice

Start date: October 30, 2023
Phase: N/A
Study type: Interventional

The present study will assess the effect and cost-effectiveness of the availability of point-of-care (POC) PCR testing, in respiratory tract infections (RTIs) in general practice, compared with usual care.

NCT ID: NCT06119256 Recruiting - Clinical trials for EBV Infection After Allogenic HSCT

Clinical Study of EBV-TCR-T Cells for EBV Infection After Allogenic HSCT

Start date: August 1, 2023
Phase: Phase 1
Study type: Interventional

This is a multi-center, single arm, open-label, phase I study to determine the safety and effectiveness of EBV-TCR-T cell immunotherapy in treating EBV virus infection after allogenic HSCT.

NCT ID: NCT06119113 Completed - Scar Clinical Trials

Wound Infection Due to Suture Material in Caesarean Skin Incision and Evaluation of Cosmetic Results

Start date: January 1, 2023
Phase: N/A
Study type: Interventional

Our primary aim is to determine the most beneficial suture in order to reduce complications due to skin incision in common surgeries such as cesarean section, and our secondary aim is to evaluate the suture material used in terms of cosmetic results and participant preference.

NCT ID: NCT06116656 Not yet recruiting - Sepsis Clinical Trials

Changes in Host Gene Expression to Differentiate Between Systemic Inflammation and Infection After Major Surgery

PAX
Start date: January 1, 2024
Phase:
Study type: Observational

Changes in host gene expression may provide additional information to diagnose postoperative infection and improve outcome after surgery. This study aims to validate the early diagnostic performance of specific gene signatures for differentiating infection from non-infected SIRS or uncomplicated postoperative course in blood sampes of adult patients undergoing major noncardiac surgery.

NCT ID: NCT06112626 Recruiting - Infections Clinical Trials

Chlorhexidine Gluconate Bathing Education Video Among Hospitalized Patients

Start date: May 1, 2024
Phase: N/A
Study type: Interventional

Chlorhexidine gluconate (CHG) bathing is an effective intervention to reduce hospitalized patient's risk of acquiring a central line-associated bloodstream infection (CLABSI). While daily CHG bathing for hospitalized patients is widely supported in the literature, patient adherence with this practice is suboptimal. Written and verbal information is provided to patients by nursing staff regarding the importance of CHG bathing and the correct usage of the CHG cloths; however, these methods can be hindered by literacy and language barriers. Medical videos have become popular avenues to provide necessary education to patients, and have been shown to improve patient-reported outcomes. Whereas the benefits of educational videos has been described in previous studies on advanced care planning and postoperative quality of life, they have not been described for CHG bathing. In this study, we aim to provide education (including the rationale/importance of CHG bathing, and the appropriate process for bathing) through the use of a short video provided to hospitalized patients. The purpose of this study is to evaluate the use of medical videos to educate patients on CHG bathing while hospitalized in the inpatient setting.

NCT ID: NCT06112249 Recruiting - Prevention Clinical Trials

SAFE Workplace Intervention for People With IDD

Start date: September 1, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the feasibility and efficacy of a systematic training approach targeting behaviors to increase safety and prevention of airborne diseases such as COVID-19 in the workplace for individuals with Intellectual and Developmental Disabilities (IDD). This project is designed to determine proof of concept and proof of product for a peer support intervention, the SAFE program, to increase knowledge and safe workplace practices. There is an identified immediate need for individuals with IDD to receive training in an accessible format. The SAFE program has been developed in an accessible format for those with IDD. It focuses on education regarding actionable behaviors that reduce the risk of acquiring and transmitting COVID-19 and other airborne diseases. The study will implement a peer-mediated and occupational therapy lead program, SAFE, to identify and address potential implementation issues and further refine the program curriculum. Additionally, the efficacy of the program on perceived safety and well-being, observable preventative behaviors and self-advocacy will be examined.

NCT ID: NCT06109688 Completed - Clinical trials for Urinary Tract Infections in Children

Effect of Lactoferrin Supplementation on Urinary Tract Infections in Infants.

Start date: July 1, 2015
Phase: Phase 3
Study type: Interventional

The aim of the study was to evaluate the efficacy of orally administered bovine lactoferrin (bLF) on Urinary Tract Infections in neonates and infants. Fifty-five patients with urinary tract infection were randomized to receive either bLF (n = 27) or an identical placebo (n = 28) for 4 weeks. The patients were assessed clinically and laboratory.

NCT ID: NCT06108791 Not yet recruiting - Clinical trials for Surgical Site Infection

Intraoperative Oxygen Concentration on Incidence of Surgical Site Infection

Start date: January 2024
Phase: N/A
Study type: Interventional

Surgical site infections (SSI) are the most common healthcare-associated infections and sources of morbidity and over-mortality. Factors that have been proven to reduce SSI include antimicrobial prophylaxis, maintenance of perioperative normothermia, avoidance of hyperglycemia, proper surgical techniques, and adequate pain relief postoperatively

NCT ID: NCT06107569 Not yet recruiting - Clinical trials for Clostridium Difficile Infections

Treatment of CDI and Recurrence With Fecal Microbiota Transplant Using Promicrobioma

Start date: May 1, 2024
Phase: Phase 3
Study type: Interventional

The increasing inappropriate use of antimicrobials, in addition to increasing selective pressure and inducing environmental resistance, is also a risk factor for the development of Clostridioides difficile infection (CDI). The intestinal microbiota is mainly composed of the phyla Firmicutes, Bacteroidetes, Acinobacteria, Proteobacteria, Fusobacteria and Verrucomicrobia, and more than 90% of the phylum Firmicutes is composed of Clostridium spp. (two). The inappropriate use of antimicrobials initiates a process of dysregulation of the microbiome, called dysbiosis, and it is from the selection of genera and species of bacteria that will dominate the intestine that pseudomembranous colitis can set in with an increased burden of Clostridioides difficile, a gram positive, anaerobic, spore-forming, that produces two enterotoxins, toxin A and toxin.

NCT ID: NCT06106698 Recruiting - Clinical trials for Clostridioides Difficile Infection

Washed Microbiota Transplantation for Clostridioides Difficile Infection

Start date: July 22, 2023
Phase:
Study type: Observational

This is a real-world study to explore the safety and the efficacy of washed microbiota transplantation (WMT) for patients with Clostridioides Difficile Infection (CDI).